Abstract:
:Maps of estimated disease rates over multiple time periods are useful tools for gaining etiologic insights regarding potential exposures associated with specific locations and times. In this paper, we describe an extension of the Gangnon-Clayton model for spatial clustering to spatio-temporal data. As in the purely spatial model, a large set of circular regions of varying radii centered at observed locations are considered as potential clusters, e.g. subregions with a different pattern of risk than the remainder of the study region. Within the spatio-temporal model, no specific parametric form is imposed on the temporal pattern of risk within each cluster. In addition to the clusters, the proposed model incorporates spatial and spatio-temporal heterogeneity effects and can readily accommodate regional covariates. Inference is performed in a Bayesian framework using MCMC. Although formal inferences about the number of clusters could be obtained using a reversible jump MCMC algorithm, we use local Bayes factors from models with a fixed, but overly large, number of clusters to draw inferences about both the number and the locations of the clusters. We illustrate the approach with two applications of the model to data on female breast cancer mortality in Japan and evaluate its operating characteristics in a simulation study.
journal_name
Stat Medjournal_title
Statistics in medicineauthors
Gangnon REdoi
10.1002/sim.3984subject
Has Abstractpub_date
2010-09-30 00:00:00pages
2325-37issue
22eissn
0277-6715issn
1097-0258journal_volume
29pub_type
杂志文章abstract::This paper discusses methods of identifying the types of missingness in quality of life (QOL) data in cancer clinical trials. The first approach involves collecting information on why the QOL questionnaires were not completed. Based on the reasons provided one may be able to distinguish the mechanisms causing missing ...
journal_title:Statistics in medicine
pub_type: 杂志文章,评审
doi:10.1002/(sici)1097-0258(19980315/15)17:5/7<739::ai
更新日期:1998-03-15 00:00:00
abstract::We have used Monte Carlo methods to compare the type I error properties of the conditional and unconditional versions of the generalized t and the generalized rank-sum tests to those of the independent samples t and Wilcoxon rank-sum tests. Results showed inflated type I errors for the conditional generalized tests bu...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780110410
更新日期:1992-02-28 00:00:00
abstract::The focus of this paper is the development of a range of cluster detection diagnostics that can be used to assess the degree to which a clustering method recovers the true clustering behaviour of small area data. The diagnostics proposed range from individual region specific diagnostics to neighbourhood diagnostics, a...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.2401
更新日期:2006-03-15 00:00:00
abstract::The relationship between association and surrogacy has been the focus of much debate in the surrogate marker literature. Recently, the individual causal association (ICA) has been introduced as a metric of surrogacy in the causal inference framework, when both the surrogate and the true endpoint are normally distribut...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.8698
更新日期:2020-11-20 00:00:00
abstract::Bayesian methods are proposed for analysing matched case-control studies in which a binary exposure variable is sometimes measured with error, but whose correct values have been validated for a random sample of the matched case-control sets. Three models are considered. Model 1 makes few assumptions other than randomn...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.2000
更新日期:2005-02-15 00:00:00
abstract::It is unclear to what extent the incremental predictive performance of a novel biomarker is impacted by the method used to control for standard predictors. We investigated whether adding a biomarker to a model with a published risk score overestimates its incremental performance as compared to adding it to a multivari...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.6165
更新日期:2014-07-10 00:00:00
abstract::In this paper, we define a modified version τ(b) of Kendall's tau to measure the association in a pair (X,Y) of random variables subject to fixed left censoring due to known lower detection limits. We provide a nonparametric estimator of τ(b) and investigate its asymptotic properties. We then assume an Archimedean cop...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4319
更新日期:2011-11-20 00:00:00
abstract::Among subjects who have experienced a biological event, such as menarche, menopause or a delivery, one cannot distinguish the effects of time since the event from age at the event due to the linear dependency among these time variables and age at study ('current age'). This is a well-known problem that also exists in ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/(SICI)1097-0258(19960730)15:14<1545::AID-S
更新日期:1996-07-30 00:00:00
abstract::In any field in which decisions are subject to measurements, interchangeability between the methods used to obtain these measurements is essential. To consider methods as interchangeable, a certain degree of agreement is needed between the measurements they provide. The concordance correlation coefficient is an index ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.2397
更新日期:2005-12-30 00:00:00
abstract::Ordinal data appear in a wide variety of scientific fields. These data are often analyzed using ordinal logistic regression models that assume proportional odds. When this assumption is not met, it may be possible to capture the lack of proportionality using a constrained structural relationship between the odds and t...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.5689
更新日期:2013-06-15 00:00:00
abstract::In longitudinal studies with incomplete data, where the number of time points can become numerous, it is often advantageous to model the covariance matrix. We describe several covariance models (for example, mixed models, compound symmetry, AR(1)-type models, and combination models) that offer parsimonious alternative...
journal_title:Statistics in medicine
pub_type: 杂志文章,评审
doi:10.1002/sim.4780141302
更新日期:1995-07-15 00:00:00
abstract::We give up-to-date methods for estimating the age-specific incidence of a disease and for estimating the effect of risk factors. We recommend taking age as the basic time scale of the analysis; then, the hazard function can be interpreted as the age-specific incidence of the disease. This choice raises a delayed entry...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/(sici)1097-0258(19980915)17:17<1973::aid-s
更新日期:1998-09-15 00:00:00
abstract::New combination regimens evaluated in phase II cancer clinical trials often show promising results compared to the standard therapy for a disease system. Selection of patients with a better prognosis can be a prominent factor for this optimism. For most disease systems, prognostic variables that are related to the out...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.706
更新日期:2001-03-30 00:00:00
abstract::Combinatorial drugs have been widely applied in disease treatment, especially chemotherapy for cancer, due to its improved efficacy and reduced toxicity compared with individual drugs. The study of combinatorial drugs requires efficient experimental designs and proper follow-up statistical modeling techniques. Linear ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.7971
更新日期:2019-01-30 00:00:00
abstract::We provide a Bayesian analysis of data categorized into two levels of age (younger than 50 years, at least 50 years) and three levels of bone mineral density (normal, osteopenia, osteoporosis) for white females at least 20 years old in the third National Health and Nutrition Examination Survey. For the sample, the age...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.1985
更新日期:2005-04-15 00:00:00
abstract::We compared eight nominal 95 per cent confidence intervals for the ratio of two Poisson parameters, both assumed small, on their true coverage (the probability that the interval includes the ratio of Poisson parameters) and median width. The commonly used log-linear interval, justified by asymptotic considerations, pr...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.3234
更新日期:2008-09-10 00:00:00
abstract::Recurrent event data are commonly encountered in health-related longitudinal studies. In this paper time-to-events models for recurrent event data are studied with non-informative and informative censorings. In statistical literature, the risk set methods have been confirmed to serve as an appropriate and efficient ap...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.1029
更新日期:2002-02-15 00:00:00
abstract::In this paper, we investigate the impact of time-invariant covariates when fitting transition mixed models. This is carried out by emphasizing on the role of baseline responses on the estimation process. Transition models are allowed for two cases of exogenous and endogenous baseline responses. We illustrate these con...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.6270
更新日期:2014-11-30 00:00:00
abstract::Genetic markers can be used as instrumental variables, in an analogous way to randomization in a clinical trial, to estimate the causal relationship between a phenotype and an outcome variable. Our purpose is to extend the existing methods for such Mendelian randomization studies to the context of multiple genetic mar...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.3843
更新日期:2010-05-30 00:00:00
abstract::Assay sensitivity has been proposed as a criterion for including psychiatric clinical outcome studies in meta-analyses. The authors assess the performance of assay sensitivity as a method for determining study appropriateness for meta-analysis by calculating expected standard drug vs placebo effect sizes for various c...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.2240
更新日期:2006-03-30 00:00:00
abstract::The "some invalid, some valid instrumental variable estimator" (sisVIVE) is a lasso-based method for instrumental variables (IVs) regression of outcome on an exposure. In principle, sisVIVE is robust to some of the IVs in the analysis being invalid, in the sense of being related to the outcome variable through pathway...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.8066
更新日期:2019-04-30 00:00:00
abstract::When asking 'what is known' about a drug or therapy or program at any time, both researchers and practitioners often confront more than a single study. Facing a variety of findings, where conflicts may outweigh agreement, how can a reviewer constructively approach the task? In this discussion, I will outline some ques...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780060304
更新日期:1987-04-01 00:00:00
abstract::Existing methods for power analysis for longitudinal study designs are limited in that they do not adequately address random missing data patterns. Although the pattern of missing data can be assessed during data analysis, it is unknown during the design phase of a study. The random nature of the missing data pattern ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.2773
更新日期:2007-07-10 00:00:00
abstract::Hospital length of stay (LOS) is an important measure of healthcare utilization and is generally positively skewed and heterogeneous. We fit a Coxian phase-type distribution to LOS and identify the hidden states of the underlying latent homogeneous Markov model. We demonstrate that selecting an appropriate number of p...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4490
更新日期:2012-06-30 00:00:00
abstract::Some clinical trials aim to demonstrate therapeutic equivalence on multiple primary endpoints. For example, therapeutic equivalence studies of agents for the treatment of osteoarthritis use several primary endpoints including investigator's global assessment of disease activity, patient's global assessment of response...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.985
更新日期:2001-11-15 00:00:00
abstract::Joint models initially dedicated to a single longitudinal marker and a single time-to-event need to be extended to account for the rich longitudinal data of cohort studies. Multiple causes of clinical progression are indeed usually observed, and multiple longitudinal markers are collected when the true latent trait of...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.6731
更新日期:2016-02-10 00:00:00
abstract::Austin Bradford Hill was once a friend to The Lancet, but, as occasionally happens, friends fall out. The great legacy of his association with the journal, however, was Principles of Medical Statistics. As each edition was succeeded by another--the first in 1937, the last in 1991--he seemed to shift his view about the...
journal_title:Statistics in medicine
pub_type: 传
doi:10.1002/1097-0258(20001215)19:23<3149::aid-sim617>
更新日期:2000-12-15 00:00:00
abstract::We use a mixed Poisson regression model with extra variation to analyse mortality data cross-classified by age and geographic region. We use estimates of dispersion parameter and fixed effects parameters, obtained by maximizing a marginal quasi-likelihood function, to estimate mortality rates in an empirical Bayes man...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/(SICI)1097-0258(19960715)15:13<1397::AID-S
更新日期:1996-07-15 00:00:00
abstract::For genome-wide association studies, we propose a new method for identifying significant biological pathways. In this approach, we aggregate data across single-nucleotide polymorphisms to obtain summary measures at the gene level. We then use a hierarchical Bayesian model, which takes the gene-level summary measures a...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4477
更新日期:2012-05-10 00:00:00
abstract::Clinical trials, especially the randomized clinical trial, have been and will remain the gold standard for the evaluation of new interventions, including pharmaceuticals, biologics, medical devices, procedures, or behavioral modifications. Despite more than five decades of experience, there are still challenges in the...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.5405
更新日期:2012-11-10 00:00:00